FDA Device Decisions, March 2025: An Over-the-Counter PCR Test for Sexually Transmitted Infections, an Endoscope Channel Cleaner and No Original PMAs
One of FDA's two De Novo grants in March 2025 went to the Visby Medical Women's Sexual Health Test (DEN240020), a PCR test that detects chlamydia, gonorrhea and trichomoniasis in a vaginal swab the user collects herself. It was granted as an over-the-counter test, with results at home.
The other De Novo was for a device that automatically cleans the narrow internal channels of a colonoscope. FDA approved no original PMAs in March.
Counting records held in RA Craft Database (decisions through August 31, 2026, tallied October 6), FDA cleared 239 510(k)s in March 2025, granted 2 De Novo requests and approved 0 original PMAs. These counts have not been reconciled with FDA's own figures. The site holds 510(k), De Novo and PMA records from 2015 onward, and counts for past months can change as the data are updated.
Counts by pathway
March 2025 next to the previous month and the same month a year earlier, with records assigned to a month by FDA decision date.
| Pathway | March 2025 | February 2025 | March 2024 |
|---|---|---|---|
| 510(k) | 239 | 232 | 278 |
| De Novo | 2 | 0 | 2 |
| PMA (original) | 0 | 2 | 1 |
| PMA supplement | 178 | 194 | 150 |
Records held in RA Craft Database, decisions through August 31, 2026.
510(k) clearances were 7 more than in February but below March 2024 (278). There were 2 De Novo grants and no original PMAs.
The busiest product codes
March's 510(k)s spread across 165 product codes. QIH (automated radiological image processing software) led with 10, followed by GEX (powered laser surgical instrument) with 7, OLO (orthopedic stereotaxic instrument) with 6, HRS (plate, fixation, bone) with 5, and DYB (introducer, catheter), ITI (wheelchair, powered), LLZ (system, image processing, radiological) and LZO (prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented) with 4 each. A single 510(k) can carry more than one product code, so per-code counts can add up to more than the number of submissions. If your code is on the list, enter it in the Product Code field on Search to see the records sorted by decision date.
De Novo: two classifications
March's two De Novo grants, both Class II, with the classification names and regulation numbers from each Classification Order:
- CORIS System (DEN240018, Nanosonics Limited): Automated endoscope channel cleaner (21 CFR 880.6994), product code SEW
- Visby Medical Women's Sexual Health Test (DEN240020, Visby Medical, Inc.): Test for detection of microorganism(s) causing sexually transmitted infections performed by lay users (21 CFR 866.3386), product code SEA
"21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.
Later devices of either type will go through 510(k).
Original PMAs: none
FDA approved no original PMAs in March. There were 178 PMA supplements, which cover changes to already approved PMA devices among other things.
Two devices worth a closer read
1. Visby Medical Women's Sexual Health Test (DEN240020, De Novo). A single-use PCR test: a woman with suspected infection collects her own vaginal swab and gets a result on the spot. The indications state that the test is not a substitute for visits to a healthcare provider. Its four special controls limit the intended use to specimens suitable for lay self-collection and testing, rule out indications such as cancer predisposition, hemorrhagic fever and viral hepatitis, require a prospective clinical study and a usability and user-comprehension study, and require labeling that tells lay users what to do after a positive or negative result. The labeling must also state limits, such as that a negative result does not rule out other pathogens and that users should see a provider after a known exposure.
2. CORIS System (DEN240018, De Novo). A device that replaces all or part of the manual cleaning of the internal channels and ports of reusable flexible endoscopes. This grant is limited to the channels of one model, the Olympus EVIS EXERA III CF-HQ190L colonovideoscope, used in healthcare facilities by trained healthcare workers. Its five special controls cover cleaning performance in simulated and actual use, cleaning-agent residue, software, human factors testing, and labeling that includes following the endoscope manufacturer's instructions.
Compare the two devices
Open DEN240020 and DEN240018, star (☆) each one, tick "Compare" on both in My Workspace and press "2 selected for comparison". The comparison table puts their Indications for Use side by side. Before relying on any of this, open "FDA Record" and "Summary PDF" on each record and read the source.
Note: months are assigned by FDA decision date, and counts can change as the data are updated each month.
RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.
← All articles